This inventor holds 2 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1994-1998.
Location History:
- Waukegan, IL (US) (1994)
- Kenosha, WI (US) (1998)
Company Filing History:
Years Active: 1994-1998
Title: The Innovative Contributions of Jill E Johnson
Introduction
Jill E Johnson is a prominent inventor based in Waukegan, IL (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies for the hepatitis C virus. With a total of 2 patents, her work has the potential to impact the diagnosis and treatment of this viral infection.
Latest Patents
Jill's latest patents include groundbreaking innovations. The first patent focuses on monoclonal antibodies to the hepatitis C virus, specifically targeting the C-100 protein, 33C protein, and CORE protein. This patent also details hybridomas that produce these monoclonal antibodies, along with methods for their use and assay kits containing these antibodies. The second patent involves monoclonal antibodies that specifically bind to the hepatitis C virus E2/NS1 antigen. This patent provides hybridoma cell lines that secrete these antibodies, methods for their application, and assay kits for related assays.
Career Highlights
Jill E Johnson is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to collaborate with other talented professionals in the field, enhancing the impact of her research.
Collaborations
Some of her notable coworkers include Smriti U Mehta and Suresh M Desai. Their collaborative efforts contribute to the advancement of research in the field of hepatitis C.
Conclusion
Jill E Johnson's innovative work in developing monoclonal antibodies for hepatitis C showcases her dedication to improving healthcare solutions. Her contributions are vital in the ongoing fight against viral infections, and her patents reflect her significant role in the field of biotechnology.